Ron Philip

Ron Philip

Director/Board Member at HARMONY BIOSCIENCES HOLDINGS, INC.

Net worth: - $ as of 31/05/2026

Health Technology
Consumer Services
Commercial Services

Profile

Ron Philip is currently Executive Chairman at CREATE Medicines, Inc. (Massachusetts) since 2026.
Mr. Philip is an Independent Director at Harmony Biosciences Holdings, Inc. since 2025, Avalo Therapeutics, Inc. since 2026, and a Director at City Therapeutics, Inc. since 2024.
Formerly, Mr. Philip was Chief Executive Officer at Spark Therapeutics, Inc. from 2022 to 2024.
Mr. Philip was President, Chief Executive Officer & Director at Orbital Therapeutics, Inc. from 2024 to 2025.
Mr. Philip served as Director at The Chamber of Commerce For Greater Philadelphia.
Mr. Philip completed undergraduate education at Drexel University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 0 ( -.--% ) - $ 31/05/2026
30/06/2026 0 ( -.--% ) - $ 31/05/2026

Ron Philip active positions

CompaniesPositionStart
HARMONY BIOSCIENCES HOLDINGS, INC. Director/Board Member 07/04/2025
AVALO THERAPEUTICS, INC. Director/Board Member 23/06/2026
Director/Board Member 01/02/2026

Former positions of Ron Philip

CompaniesPositionEnd
Chief Executive Officer 01/12/2025
SPARK THERAPEUTICS, INC. Chief Executive Officer 01/09/2024
Director/Board Member -
See the detail of Ron Philip's experience

Training of Ron Philip

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

17

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology